Medical isotope innovation depends on more than a stronger particle beam

European accelerator laboratories are widening access to radionuclides for cancer research. Their industrial value depends on connecting production with purity, measurement, timely delivery and the evidence needed to investigate a medicine.

The post Medical isotope innovation depends on more than a stronger particle beam appeared first on Innovation News Network.